TherapeutAix

What TherapeutAix does

TherapeutAix is a life sciences consultancy founded in 2018 and headquartered in Aachen, Germany, structured as a private UG (haftungsbeschränkt) German entity. The firm provides drug development strategy and translational science advisory services, with particular specialization in fibrotic disease, inflammation, and orphan indications. Its client base consists primarily of small and mid-sized pre-clinical and clinical-stage biotechnology companies seeking external scientific expertise to guide portfolio and program decisions.

The consultancy's service portfolio spans drug development strategy, translational science, pharmacokinetic/pharmacodynamic (PK/PD) study design, and structured workshops for biotech clients. A distinctive commercial tactic is the offering of a complimentary initial project review, which the firm reports converts into paid engagements at a rate exceeding 90%. Its professional staff includes four directors whose collective industry experience exceeds 100 years, all of whom previously held roles within Grünenthal's Inflammation/Modulatory Units (IMU). Technical delivery is augmented by an ecosystem of seven named third-party partnerships covering analytical chemistry, bioanalytics, imaging, protein sciences, immunology, and biomarker capabilities.

The business operates on a professional services revenue model combining hourly consulting rates and fixed-fee project engagements. Customer references include MarraBio, ReNewVax, Inspira Pharmaceuticals, Sitryx, and Odin Therapeutics. The firm claims global reach, though engagement patterns indicate primary concentration across EMEA with selective US clients. Headcount sits between 1-10 employees, consistent with a boutique consultancy model, and the company has not raised external funding rounds.

Name

TherapeutAix

Legal name

TherapeutAix UG (haftungsbeschränkt)

Website

https://therapeutaix.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

TherapeutAix is a boutique life sciences consultancy founded in 2018 in Aachen, Germany, providing drug development strategy and translational science advisory to small and mid-sized biotechs, with specialization in fibrotic disease, inflammation, and orphan indications.

Ownership category

akta.pro rank

Product category

Pharmaceutical Consulting Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

akta.pro secondary industries

Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI)

Keywords

• Drug development consulting
• Life sciences consulting
• Translational science services
• Clinical development strategy
• Pharmaceutical R&D advisory

Headquarters

HQ city

Aachen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Consulting Services: Professional consulting services ranging from strategic advice to full project management and operationalisation. They offer flexible contracting models including hourly rates within agreed scope and fixed-fee projects. They quote fees for set packages of work where costs are fixed regardless of time taken.
2. Workshop Facilitation: Bespoke workshop organization and moderation, including both client-specific workshops and crowd-funded consortium workshops where multiple companies share costs for precompetitive analysis.
3. Free Initial Review: Free-of-charge initial project review offered to potential clients to assess projects and demonstrate value before formal engagement. This serves as a lead generation mechanism.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

TherapeutAix is a life sciences consultancy that combines subject matter expertise with a fully integrated R&D network to deliver practical, cost and time-efficient drug development solutions spanning preclinical, translational, and clinical phases through to proof-of-concept. The firm provides bespoke services ranging from advisory engagements to full project management and operationalisation, with a free initial project review offered to prospective clients and a three-stage methodology (Review, Strategy, Operations) underpinning engagements.

Product overview

TherapeutAix is a life sciences consultancy company offering a unified portfolio of drug development services. The core offering combines strategic consulting with a fully integrated R&D network to deliver practical solutions across the drug discovery continuum. Services include a complimentary initial project review, therapeutic area consulting (specializing in fibrotic diseases, cardiovascular, inflammation, immunology, neuroscience, respiratory, pain, tissue repair, and urology), translational science services, PK/PD design, bespoke workshop facilitation, and project strategy development. The company operates a three-stage approach: Review, Strategy, and Operations, ranging from advisory services to full project management and operationalisation.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Development Strategy Consulting Strategic consulting services combining subject matter expertise with a fully integrated R&D network to deliver practical, cost and time-efficient solutions for drug discovery projects from preclinical through clinical proof-of-concept.
• Free Initial Project Review A complimentary assessment of client projects allowing TherapeutAix to evaluate the project and demonstrate how they can work together, with over 90% of reviewed projects resulting in client engagements.
• Therapeutic Area Consulting Expert consulting in cardiovascular, inflammation, immunology, neuroscience, respiratory, pain, tissue repair, urology, and fibrotic diseases including NASH and IPF, with specialization in biomarkers and translational science.
• Translational Science Services Building translational strategies derived from understanding of target and disease biology with emphasis on models with human origin, including in vitro models with human cells or tissues, target engagement confirmation, and mechanistic animal models.
• PK/PD Design Services Design of optimal PK/PD packages that build confidence in target modulation and set foundations for successful clinical translation, with biomarker and disease endpoint assessments.
• Workshop Services Bespoke workshop formats for project teams ranging from data review to strategic discussions, including open innovation workshops and crowd-funded consortium workshops for precompetitive program aspects.
• Project Strategy Development Collaborative development of strategic objectives and design of future-proof evidence platforms that meet customer expectations, including optimal strategic positioning for developmental drugs.

Quantifiable outcome

• Over 90% client conversion rate from free initial review to paid engagement
• +1 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and supporting.

• Alderley AnalyticalcoreTechnology or Integration · 1 January 2020Independent contract research organisation based at Alderley Park, Cheshire, UK, offering specialist bioanalytical services supporting drug development programs from discovery through clinical development. TherapeutAix began collaborating with them in 2020 after successfully helping a client overcome a challenging PK/PD situation. Collaboration includes dedicated project teams for integrated service delivery.
• Peak ProteinscoreTechnology or Integration · 1 January 2020Contract research organisation based at Alderley Park, Cheshire, UK, providing tailor-made protein reagents, protein structure information using X-ray crystallography, and protein mass spectrometry. Collaboration began in 2020 after successfully helping a client overcome a PK/PD challenge. Dedicated project teams formed for integrated service delivery.
• ApconiXcoreTechnology or Integration · 1 January 2018Integrated toxicology consultancy and ion channel laboratory specialising in nonclinical toxicology and safety science. Founded by former AstraZeneca colleagues, ApconiX provides drug discovery and development services to academic, biotech, and large pharmaceutical companies. TherapeutAix started working with them in 2018, referring clients requiring toxicology expertise while ApconiX refers clients needing broader project strategy support.
• BoydscoreStrategic or Co-development PartnerPharmaceutical consultancy working with pharma companies, biotechs, and spin-outs to support new medicine development. Specialises in orphan drug discovery, rare diseases, and offers clinical and regulatory insight. Partnership provides TherapeutAix clients with access to clinical and regulatory expertise and creative options for early clinical development strategy.
• Immunoconsulting LimitedsupportingTechnology or IntegrationConsulting firm assisting biopharmaceutical companies developing therapeutic strategies targeting immune system components across therapy areas. Led by Andrew Leishman with 20+ years of industry experience. Combined expertise enables high-quality analysis for immunology-focused projects, particularly immuno-oncology. Joint workshops have helped develop Target Product Profiles addressing clinical and partnering priorities.
• Nordic BiosciencecoreStrategic or Co-development PartnerWorks in preclinical and clinical drug development, specialising in precision medicine using unique biomarker technologies to stratify patient populations and inform clinical trial design. Liaises with biotech and pharmaceutical clients to build pre-clinical disease understanding and develop biomarker-led strategies for early clinical proof of concept.
• OracleBiocoreTechnology or IntegrationHighly specialised image analysis CRO providing high precision, quantitative, digital image analysis services for pre-clinical and clinical research. Also offers integrated services covering ethical tissue procurement, histology, and immunohistochemistry. Has expertise in fibrosis, autoimmune disease, and oncology. Partnership enables TherapeutAix to access translational studies in animal models and human tissue.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Catenion: Berlin-based biopharma strategy consulting firm advising biotech and pharma clients on R&D portfolio strategy, project evaluation, and translational decision-making. Closely comparable boutique profile with similar senior-consultant-led model and drug development advisory focus.
• Health Advances: US-based strategy consulting firm focused exclusively on biopharma, supporting biotech and medtech clients with corporate strategy, product commercialization, and R&D portfolio decisions. Comparable boutique biopharma advisory serving similar customer profile with similar senior-consultant delivery model.
• Boyds: UK-based pharmaceutical consultancy supporting biotechs, spin-outs, and pharma companies with clinical and regulatory strategy in orphan and rare diseases. Directly comparable in size, therapeutic focus (specialist biotech advisory), and customer base, and is in fact a formal partner of TherapeutAix.
• Defined Health: US boutique biopharma strategic consulting firm advising emerging and established biopharma companies on therapeutic strategy, commercialization, and business development. Closely comparable in scale, therapeutic-area specialization, and biotech client focus.
• Alacrita: UK/US life sciences consulting firm providing strategic and operational support to biotech and pharma, including drug development strategy. Comparable boutique profile with similar drug development advisory scope.
• ClearView Healthcare Partners: US-based life sciences consulting firm providing strategic insights across therapeutic areas to pharma, biotech, and investors. Comparable in boutique scale, therapeutic strategy focus, and target customer base (biotech and pharma R&D leaders).
• Kineticos Life Sciences: US-based life sciences consulting firm advising biotech and pharma on strategy, M&A, and operational execution. Comparable boutique size with similar therapeutic-area strategy and biotech R&D advisory services.

Broad incumbents

• PharmaLex (Cencora): Large global life sciences consulting firm (now part of Cencora/Alliance Healthcare) offering regulatory, clinical, and drug development strategy services. Comparable in drug development advisory scope but broader in geographic footprint and service portfolio.
• Charles River Laboratories: Global CRO offering preclinical and clinical drug discovery and development services. Adjacent through its preclinical/translational and consulting capabilities, though much larger and broader in service scope than TherapeutAix's advisory-led model.
• IQVIA: Global clinical research services, commercial analytics, and consulting firm serving pharma and biotech across the full drug development lifecycle. Adjacent through its R&D strategy and consulting capabilities, though vastly larger and broader than TherapeutAix.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/therapeutaix
• LinkedInlinkedin.com/company/therapeutaix

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TherapeutAix